Skip to main content

Table 1 Overview of important in vivo and in vitro studies (with either a large number of CIEDs or interesting findings, excluding reviews)

From: Management of radiation oncology patients with a pacemaker or ICD: A new comprehensive practical guideline in The Netherlands

Year

First author

Study type

Number of PM included

Number of ICD included

Intervention: Max Dose in study(Gy)

Number of defects

type of defect

2010

Ferrara

Prospective in vivo

37

8

< 2,5

No defects

No defects

2010

Wadasadawala

Review+ 8 pacemakers

8

0

60

No defects

No defects

2009

Zweng

case report

1

0

0.11

1[1] @ 0.11 Gy

runaway PM

2009

Gelblum

Retrospective in vivo

0

33

<3

1[33] @3 Gy

Reset to factory settings

2008

Lau

case report

0

1

<0,15

1[1] @ 0,15 Gy

electrical reset

2008

Kapa

in vitro research + in vivo retrospective

7 (in vivo)

20 (in vitro) 5 (in vivo)

< 4 (in vitro) unreported for in vivo

No defects

No defects, 4 devices relocated before RT

2008

Munshi[52]

case report

1

 

4.3

No defects

No defects

2007

Nemec

case report

0

1

< 6

1[1] @ <1 Gy*

Runaway ICD

2005

Hurkmans[24]

in vitro research

19

0

< 120

14[19] @ 120 Gy 1[19] @ 20 Gy

Output, sense and communication

2005 2006

Hurkmans Uiterwaal[24]

in vitro research

0

11

< 120

11[11]@120 Gy (irreversible) 4[11]@ 0,5 Gy (minor defects)

To low shock energy, sensing and Battery charge time, erroneous VF or VT detection.

2004

John

case report

0

1

50

1[1] @ not reported dose

shock impedance (coil failure)

2002

Mouton

in vitro research

96

0

200

4(96) @ 0,2 Gy 21(96)@2 Gy >0.2 Gy/min

8 defect modes described

2001

Niehaus

Review+ in vivo research

0

3

< 5

no defects

No defects

2000

Tsekos

case report

1

0

< 50

1[1] @ not reported dose

Decrease of battery load

1994

Souliman

in vitro research

18

0

70

11[18] @ 7,0 Gy 2[18] @ 1,7 Gy 5[18] @ 2,5 Gy

1) temporary change to interference or safety mode pacing lasting for the duration of the irradiation only[2] change to interference mode pacing—from which recovery may occur after reprogramming the pacemaker[3] severe damage

1994

Wilm[53]

in vitro research

20

0

300

2[20] @ 10 Gy (complete defects)

Complete defect, decrease of pace amplitude, loss of telemetry

1991

Rodriguez

in vitro research

23

4

< 50

1[23] @ 14 Gy 11[23] sensitivity 9[23] telemetry

sensitivity, telemetry and total defect

  1. * estimated from the case report.